COUCHMAN JONATHAN 13D and 13G filings for Enzon Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-09-17 4:12 pm Unchanged | 2020-09-15 | 13D | Enzon Pharmaceuticals, Inc. ENZN | COUCHMAN JONATHAN | 7,851,454 17.800% | 0 (Unchanged) | Filing |
| 2020-08-05 4:59 pm Purchase | 2020-08-03 | 13D | Enzon Pharmaceuticals, Inc. ENZN | COUCHMAN JONATHAN | 7,851,454 17.800% | 506,292 (+6.89%) | Filing |
| 2020-04-16 5:00 pm Unchanged | 2020-04-08 | 13D | Enzon Pharmaceuticals, Inc. ENZN | COUCHMAN JONATHAN | 7,345,162 16.600% | 0 (Unchanged) | Filing |
| 2020-03-27 5:27 pm Purchase | 2020-03-18 | 13G | Enzon Pharmaceuticals, Inc. ENZN | COUCHMAN JONATHAN | 7,345,162 16.600% | 1,557,996 (+26.92%) | Filing |